Literature DB >> 15591789

Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells.

Karen Man-Fong Sze1, Yick-Pang Ching, Dong-Yan Jin, Irene Oi-Lin Ng.   

Abstract

Chromosomal instability (CIN) refers to high rates of chromosomal gains and losses and is a major cause of genomic instability of cells. It is thought that CIN caused by loss of mitotic checkpoint contributes to carcinogenesis. In this study, we evaluated the competence of mitotic checkpoint in hepatoma cells and investigated the cause of mitotic checkpoint defects. We found that 6 (54.5%) of the 11 hepatoma cell lines were defective in mitotic checkpoint control as monitored by mitotic indices and flow-cytometric analysis after treatment with microtubule toxins. Interestingly, all 6 hepatoma cell lines with defective mitotic checkpoint showed significant underexpression of mitotic arrest deficient 2 (MAD2), a key mitotic checkpoint protein. The level of MAD2 underexpression was significantly associated with defective mitotic checkpoint response (p < 0.001). In addition, no mutations were found in the coding sequences of MAD2 in all 11 hepatoma cell lines. Our findings suggest that MAD2 deficiency may cause a mitotic checkpoint defect in hepatoma cells. 2004 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591789     DOI: 10.1007/bf02254377

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  8 in total

Review 1.  Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy.

Authors:  A Ogden; P C G Rida; R Aneja
Journal:  Cell Death Differ       Date:  2012-06-01       Impact factor: 15.828

2.  Reduced expression of cenp-e in human hepatocellular carcinoma.

Authors:  Zijie Liu; Kang Ling; Xia Wu; Ju Cao; Bin Liu; Suyan Li; Qiong Si; Yan Cai; Chen Yan; Yan Zhang; Yaguang Weng
Journal:  J Exp Clin Cancer Res       Date:  2009-12-18

3.  Gene profiling of early and advanced liver disease in chronic hepatitis C patients.

Authors:  Saira Sarfraz Khalid; Saeed Hamid; Anwar A Siddiqui; Asaf Qureshi; Nilofer Qureshi
Journal:  Hepatol Int       Date:  2011-01-22       Impact factor: 6.047

Review 4.  Human T-cell leukemia virus type 1 Tax and cellular transformation.

Authors:  Jean-Marie Peloponese; Takao Kinjo; Kuan-Teh Jeang
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

5.  BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).

Authors:  Y Niikura; H Ogi; K Kikuchi; K Kitagawa
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

Review 6.  Mitotic chromosomal instability and cancer: mouse modelling of the human disease.

Authors:  Juan-Manuel Schvartzman; Rocio Sotillo; Robert Benezra
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

7.  A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage.

Authors:  Mariana F Gayyed; Nehad M R Abd El-Maqsoud; Ehab Rifat Tawfiek; Saad Abdelnaby A El Gelany; Mohamed Fathy Abdel Rahman
Journal:  Tumour Biol       Date:  2015-08-06

8.  Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus‑positive cirrhosis.

Authors:  Qi-Feng Chen; Jin-Guo Xia; Wang Li; Lu-Jun Shen; Tao Huang; Peihong Wu
Journal:  Mol Med Rep       Date:  2018-09-19       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.